CYP2D6 Polymorphism Clinical Trial
Official title:
Effects of Isotretinoin on CYP2D6 Activity
Specific Aim: To investigate if isotretinoin (13-cis-retinoic acid) administration decreases CYP2D6 activity in adolescent patients.
In this aim, we will conduct a drug-drug interaction study evaluating the effects of 13-cis-retinoic acid on non-induced CYP2D6 activity in adolescent patients. Secondary analysis will evaluate the relationship between retinoid concentrations and CYP2D6 activity in these special populations ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04228315 -
Biomarkers of P. Vivax Relapse
|
N/A | |
Completed |
NCT01075802 -
Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms
|
N/A | |
Completed |
NCT03117660 -
Effects of Retinoids on CYP2D6 Activity During Pregnancy
|
Phase 1 | |
Completed |
NCT03411759 -
Cytochrome P450's Pharmacogenomics in Chronic Pain Patients
|
||
Completed |
NCT02428660 -
Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM
|
N/A | |
Enrolling by invitation |
NCT03137368 -
A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations (STEP)
|
Phase 3 | |
Completed |
NCT02664350 -
Precision Medicine Guided Treatment for Cancer Pain
|
N/A |